NasdaqCM - Nasdaq Real Time Price USD
Vivani Medical, Inc. (VANI)
At close: November 6 at 4:00 PM EST
After hours: November 6 at 5:40 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
26,591.0000
26,965.0000
21,241.0000
13,323.0000
9,243.0000
Operating Income
-26,591.0000
-26,965.0000
-21,241.0000
-13,323.0000
-9,243.0000
Other Income Expense
1,218.0000
1,313.0000
7,352.0000
550.0000
-36.0000
Pretax Income
-25,373.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Net Income Common Stockholders
-25,373.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Diluted NI Available to Com Stockholders
-25,373.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Basic EPS
-0.46
-0.50
-0.36
-0.39
-0.28
Diluted EPS
-0.46
-0.50
-0.36
-0.39
-0.28
Basic Average Shares
52,285.0000
50,853.0000
38,241.0000
33,092.0000
33,092.0000
Diluted Average Shares
52,285.0000
50,853.0000
38,241.0000
33,092.0000
33,092.0000
Total Operating Income as Reported
-26,591.0000
-26,965.0000
-21,241.0000
-13,323.0000
-9,243.0000
Total Expenses
26,591.0000
26,965.0000
21,241.0000
13,323.0000
9,243.0000
Net Income from Continuing & Discontinued Operation
-25,373.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Normalized Income
-25,373.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
EBIT
-26,591.0000
-26,965.0000
-21,241.0000
-13,323.0000
-9,243.0000
EBITDA
-26,243.0000
-26,608.0000
-20,860.0000
-12,978.0000
-8,889.0000
Reconciled Depreciation
348.0000
357.0000
381.0000
345.0000
354.0000
Net Income from Continuing Operation Net Minority Interest
-25,373.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Total Unusual Items Excluding Goodwill
641.0000
--
6,877.0000
--
--
Total Unusual Items
641.0000
--
6,877.0000
--
--
Normalized EBITDA
-26,243.0000
-26,608.0000
-20,860.0000
-12,978.0000
-8,889.0000
12/31/2020 - 11/19/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RLMD Relmada Therapeutics, Inc.
3.4000
+2.41%
NKGN NKGen Biotech, Inc.
0.2700
+4.25%
DRMA Dermata Therapeutics, Inc.
1.3500
+7.14%
BPTH Bio-Path Holdings, Inc.
0.8700
-11.18%
HOTH Hoth Therapeutics, Inc.
0.8810
-1.78%
AZTR Azitra, Inc.
0.4941
+2.77%
ADIL Adial Pharmaceuticals, Inc.
1.0100
0.00%
ENVB Enveric Biosciences, Inc.
0.4653
-1.04%
SNSE Sensei Biotherapeutics, Inc.
0.5234
+4.60%
XCUR Exicure, Inc.
2.5800
-10.73%